negative effects of glp 1 agonists Part 2 a 3-Part Series; GLP-1 Medications for Weight Loss Long-Term Effects Of GLP-1 Medications:
Description
They were randomly assigned in a 2:1 ratio, to 68 weeks of treatment with semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
Predefined sensitivity analyses to determine potential confounding influence were conducted with the same statistical analysis set-up removing (1) patients with IIH without papilledema (IIH-WOP), and (2) patients with pre-existing migraine
While they have some similarities, there are also important differences in their mechanisms of action and side effect profiles
doi:10.1038/nm727 321
License: CC BY-NC-SA 3.0 IGO
doi: 10.1515/RNS.2011.044 30 CollingridgeG
